Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$80.11 - $90.62 $281,266 - $318,166
-3,511 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$79.7 - $88.13 $38,096 - $42,126
478 Added 15.76%
3,511 $307,000
Q3 2021

Nov 04, 2021

SELL
$81.78 - $95.14 $66,078 - $76,873
-808 Reduced 21.04%
3,033 $248,000
Q2 2021

Aug 09, 2021

BUY
$85.24 - $94.15 $114,818 - $126,820
1,347 Added 54.01%
3,841 $351,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $22,879 - $26,980
-274 Reduced 9.9%
2,494 $213,000
Q4 2020

Feb 09, 2021

SELL
$78.07 - $94.43 $28,417 - $34,372
-364 Reduced 11.62%
2,768 $261,000
Q3 2020

Nov 05, 2020

SELL
$82.14 - $91.0 $3,942 - $4,368
-48 Reduced 1.51%
3,132 $272,000
Q2 2020

Jul 30, 2020

SELL
$80.93 - $91.1 $13,434 - $15,122
-166 Reduced 4.96%
3,180 $278,000
Q1 2020

May 08, 2020

BUY
$70.67 - $99.01 $78,302 - $109,703
1,108 Added 49.51%
3,346 $276,000
Q4 2019

Feb 06, 2020

BUY
$84.35 - $95.37 $188,775 - $213,438
2,238 New
2,238 $212,000
Q3 2019

Oct 29, 2019

SELL
$85.54 - $94.26 $188,444 - $207,654
-2,203 Closed
0 $0
Q2 2019

Aug 29, 2019

BUY
$75.4 - $92.8 $166,106 - $204,438
2,203 New
2,203 $201,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $228B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.